Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

Open Access 06-02-2024 | Review Article

Guardians of precision: advancing radiation protection, safety, and quality systems in nuclear medicine

Authors: Francesco Giammarile, Peter Knoll, Jolanta Kunikowska, Diana Paez, Enrique Estrada Lobato, Miriam Mikhail-Lette, Richard Wahl, Ola Holmberg, May Abdel-Wahab, Andrew M. Scott, Roberto C. Delgado Bolton

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 6/2024

Abstract

Background

In the rapidly evolving field of nuclear medicine, the paramount importance of radiation protection, safety, and quality systems cannot be overstated. This document provides a comprehensive analysis of the intricate regulatory frameworks and guidelines, meticulously crafted and updated by national and international regulatory bodies to ensure the utmost safety and efficiency in the practice of nuclear medicine.

Methods

We explore the dynamic nature of these regulations, emphasizing their adaptability in accommodating technological advancements and the integration of nuclear medicine with other medical and scientific disciplines.

Results

Audits, both internal and external, are spotlighted for their pivotal role in assessing and ensuring compliance with established standards, promoting a culture of continuous improvement and excellence. We delve into the significant contributions of entities like the International Atomic Energy Agency (IAEA) and relevant professional societies in offering universally applicable guidelines that amalgamate the latest in scientific research, ethical considerations, and practical applicability.

Conclusions

The document underscores the essence of international collaborations in pooling expertise, resources, and insights, fostering a global community of practice where knowledge and innovations are shared. Readers will gain an in-depth understanding of the practical applications, challenges, and opportunities presented by these regulatory frameworks and audit processes. The ultimate goal is to inspire and inform ongoing efforts to enhance safety, quality, and effectiveness in nuclear medicine globally.

International Atomic Energy Agency (IAEA). Radiation protection and safety of radiation sources: international basic safety standards. IAEA Safety Standards Series No. GSR Part 3. Vienna: IAEA. 2014. https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1578_web-57265295.pdf Last accessed 2 November 2023

Herrmann K, Giovanella L, Santos A, Gear J, Kiratli PO, Kurth J, et al. Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre. Eur J Nucl Med Mol Imaging. 2022;49:2300–9. https://doi.org/10.1007/s00259-022-05785-x.CrossRefPubMedPubMedCentral

Gillings N, Hjelstuen O, Ballinger J, Behe M, Decristoforo C, Elsinga P, et al. Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals. EJNMMI Radiopharm Chem. 2021;6:8. https://doi.org/10.1186/s41181-021-00123-2.CrossRefPubMedPubMedCentral

Patt M, Decristoforo C, de Martini A, Koole M, Oyen WJG, Kiss OC. The revision of the pharmaceutical legislation - it is time to act for nuclear medicine in Europe. Eur J Nucl Med Mol Imaging. 2023;51(1):20–4. https://doi.org/10.1007/s00259-023-06472-1.CrossRefPubMedPubMedCentral

European Association of Nuclear Medicine and Nuclear Medicine Europe joint statement on the revision of the European Pharmaceutical Legislation Time to Act for Nuclear Medicine. https://www.eanm.org/content-eanm/uploads/2023/10/EANM-NMEU-joint-communication-on-Pharma-Law.pdf. Accessed 2 Nov 2023.

Delgado Bolton RC, Giammarile F, Howlett DC, Jornet N, Brady AP, Coffey M, et al. The QuADRANT study: current status and recommendations for improving uptake and implementation of clinical audit of medical radiological procedures in Europe-the nuclear medicine perspective. Eur J Nucl Med Mol Imaging. 2023;50:2576–81. https://doi.org/10.1007/s00259-023-06203-6.CrossRefPubMed

Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al; European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54. https://doi.org/10.1007/s00259-014-2961-x.

Cherry SR, Sorenson JA, Phelps ME. Physics in nuclear medicine. 4th ed. Philadelphia: Saunders; 2012.

Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, et al. EANM procedure guidelines for radionuclide therapy with ¹⁷⁷Lu-labelled PSMA-ligands (¹⁷⁷Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2019;46:2536–44. https://doi.org/10.1007/s00259-019-04485-3.CrossRefPubMed

10.

Delgado Bolton RC, Aide N, Colletti PM, Ferrero A, Paez D, Skanjeti A, Giammarile F. EANM guideline on the role of 2-[¹⁸F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA). Eur J Nucl Med Mol Imaging. 2021;48:3286–302. https://doi.org/10.1007/s00259-021-05450-9.CrossRefPubMed

11.

Adam JA, Loft A, Chargari C, Delgado Bolton RC, Kidd E, Schöder H, et al. EANM/SNMMI practice guideline for [18F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0. Eur J Nucl Med Mol Imaging. 2021;48:1188–99. https://doi.org/10.1007/s00259-020-05112-2.CrossRefPubMed

12.

Vaz SC, Adam JA, Delgado Bolton RC, Vera P, van Elmpt W, Herrmann K, et al. Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0. Eur J Nucl Med Mol Imaging. 2022;49:1386–406. https://doi.org/10.1007/s00259-021-05624-5.CrossRefPubMedPubMedCentral

13.

Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, et al. Joint EANM/SNMMI procedure guideline for the use of ¹⁷⁷Lu-labeled PSMA-targeted radioligand-therapy (¹⁷⁷Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2023;50:2830–45. https://doi.org/10.1007/s00259-023-06255-8.CrossRefPubMedPubMedCentral

14.

Veit-Haibach P, Ahlström H, Boellaard R, Delgado Bolton RC, Hesse S, Hope T, et al. International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology. Eur J Nucl Med Mol Imaging. 2023;50:3513–37. https://doi.org/10.1007/s00259-023-06406-x.CrossRefPubMedPubMedCentral

15.

Beets G, Sebag-Montefiore D, Andritsch E, Arnold D, Beishon M, Crul M, et al. ECCO essential requirements for quality cancer care: colorectal cancer. A critical review. Crit Rev Oncol Hematol. 2017;110:81–93. https://doi.org/10.1016/j.critrevonc.2016.12.001.CrossRefPubMed

16.

Andritsch E, Beishon M, Bielack S, Bonvalot S, Casali P, Crul M, et al. ECCO Essential requirements for quality cancer care: soft tissue sarcoma in adults and bone sarcoma. A critical review. Crit Rev Oncol Hematol. 2017;110:94–105. https://doi.org/10.1016/j.critrevonc.2016.12.002.CrossRefPubMed

17.

Wouters MW, Michielin O, Bastiaannet E, Beishon M, Catalano O, Del Marmol V, et al. ECCO essential requirements for quality cancer care: melanoma. Crit Rev Oncol Hematol. 2018;122:164–78. https://doi.org/10.1016/j.critrevonc.2017.12.020.CrossRefPubMed

18.

Allum W, Lordick F, Alsina M, Andritsch E, Ba-Ssalamah A, Beishon M, et al. ECCO essential requirements for quality cancer care: oesophageal and gastric cancer. Crit Rev Oncol Hematol. 2018;122:179–93. https://doi.org/10.1016/j.critrevonc.2017.12.019.CrossRefPubMed

19.

Brausi M, Hoskin P, Andritsch E, Banks I, Beishon M, Boyle H, et al. ECCO essential requirements for quality cancer care: prostate cancer. Crit Rev Oncol Hematol. 2020;148:102861. https://doi.org/10.1016/j.critrevonc.2019.102861.CrossRefPubMed

20.

Biganzoli L, Cardoso F, Beishon M, Cameron D, Cataliotti L, Coles CE, et al. The requirements of a specialist breast centre. Breast. 2020;51:65–84. https://doi.org/10.1016/j.breast.2020.02.003.CrossRefPubMedPubMedCentral

21.

Berghmans T, Lievens Y, Aapro M, Baird AM, Beishon M, Calabrese F, et al. European Cancer Organisation essential requirements for quality cancer care (ERQCC): lung cancer. Lung Cancer. 2020;150:221–39. https://doi.org/10.1016/j.lungcan.2020.08.017.CrossRefPubMed

22.

Delgado Bolton RC, Calapaquí Terán AK, Erba PA, Giammarile F. Medical imaging in times of pandemic: focus on the cornerstones of successful imaging. Eur J Nucl Med Mol Imaging. 2021;48:1724–5. https://doi.org/10.1007/s00259-021-05331-1.CrossRefPubMedPubMedCentral

23.

Thrall JH, Ziessman HA, Fahey FH. Nuclear medicine: the requisites. 5th ed. Philadelphia: Elsevier; 2021.

24.

International Atomic Energy Agency (IAEA). Radiopharmaceuticals for positron emission tomography: production and quality control. IAEA-TECDOC-1607. Vienna: IAEA. 2008.

25.

Sollini M, Gelardi F, Matassa G, Delgado Bolton RC, Chiti A, Kirienko M. Interdisciplinarity: an essential requirement for translation of radiomics research into clinical practice -a systematic review focused on thoracic oncology. Rev Esp Med Nucl Imagen Mol. 2020;39:146–56. https://doi.org/10.1016/j.remn.2019.10.003.CrossRefPubMed

26.

Delgado Bolton RC, Calapaquí Terán AK, Fanti S, Giammarile F. New biomarkers with prognostic impact based on multitracer PET/CT imaging in neuroendocrine neoplasms: the light leading out of the darkness in challenging tumors. Clin Nucl Med. 2022;1(47):219–20. https://doi.org/10.1097/RLU.0000000000004062.CrossRef

27.

Delgado Bolton RC, Calapaquí Terán AK, Fanti S, Giammarile F. The concept of strength through synergy applied to the search of powerful prognostic biomarkers in gastroesophageal cancer: an example based on combining clinicopathological parameters, imaging-derived sarcopenia measurements, and radiomic features. Clin Nucl Med. 2023;48:156–7. https://doi.org/10.1097/RLU.0000000000004357.CrossRefPubMed

28.

Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD: radionuclide data and decay schemes. 2nd ed. Reston: Society of Nuclear Medicine; 2009.

29.

Kayal G, Barbosa N, Marín CC, Ferrer L, Fragoso-Negrín JA, Grosev D, et al. Quality assurance considerations in radiopharmaceutical therapy dosimetry using PLANETDose: an international aAtomic energy agency study. J Nucl Med. 2024;65(1):125–31. https://doi.org/10.2967/jnumed.122.265340.

30.

Giammarile F, Muylle K, Delgado Bolton R, Kunikowska J, Haberkorn U, Oyen W. Dosimetry in clinical radionuclide therapy: the devil is in the detail. Eur J Nucl Med Mol Imaging. 2017;44:2137–9. https://doi.org/10.1007/s00259-017-3820-3.CrossRefPubMed

31.

International Atomic Energy Agency. Nuclear medicine physics. Vienna: Non-serial Publications, IAEA; 2015.

32.

Ma SX, Dhanaliwala AH, Rudie JD, Rauschecker AM, Roberts-Wolfe D, Haddawy P, Kahn CE Jr. Bayesian networks in radiology. Radiol Artif Intell. 2023;5(6):e210187. https://doi.org/10.1148/ryai.210187.CrossRefPubMedPubMedCentral

33.

Wendler T, Kreissl MC, Schemmer B, Rogasch JMM, De Benetti F. Artificial intelligence-powered automatic volume calculation in medical images - available tools, performance and challenges for nuclear medicine. Nuklearmedizin. 2023;62(6):343–53. https://doi.org/10.1055/a-2200-2145.CrossRefPubMedPubMedCentral

34.

Delbeke D, Segall GM. Status of and trends in nuclear medicine in the United States. J Nucl Med. 2011;52(suppl 2):24S-28S.CrossRefPubMed

35.

International Atomic Energy Agency, Dosimetry for radiopharmaceutical therapy [IAEA preprint], [Link]. 2022. (https://preprint.iaea.org/search.aspx?orig_q=RN:53037189) Last accessed 2 November 2023.

36.

Almeida LS, Etchebehere ECSC, García Megías I, Calapaquí Terán AK, Hadaschik B, Colletti PM, et al. PSMA radioligand therapy in prostate cancer: where are we and where are we heading? Clin Nucl Med. 2024;49:45–55. https://doi.org/10.1097/RLU.0000000000004919.CrossRefPubMed

37.

Goldsmith SJ. Targeted radionuclide therapy: a historical and personal review. Semin Nucl Med. 2020;50(1):87–97. https://doi.org/10.1053/j.semnuclmed.2019.07.006.CrossRefPubMed

38.

Pomykala KL, Hadaschik BA, Sartor O, Gillessen S, Sweeney CJ, Maughan T, Hofman MS, Herrmann K. Next generation radiotheranostics promoting precision medicine. Ann Oncol. 2023;34(6):507–19. https://doi.org/10.1016/j.annonc.2023.03.001.CrossRefPubMed

Title: Guardians of precision: advancing radiation protection, safety, and quality systems in nuclear medicine
Authors: Francesco Giammarile
Peter Knoll
Jolanta Kunikowska
Diana Paez
Enrique Estrada Lobato
Miriam Mikhail-Lette
Richard Wahl
Ola Holmberg
May Abdel-Wahab
Andrew M. Scott
Roberto C. Delgado Bolton
Publication date: 06-02-2024
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 6/2024
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-024-06633-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Guardians of precision: advancing radiation protection, safety, and quality systems in nuclear medicine

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2024

Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy

[68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis

Neuronal intranuclear inclusion disease with cerebellar white matter tau uptake and incidental meningioma

False-positive [18F]FAPI-74 uptake caused by blood retention due to external jugular vein thrombus: Pitfall in the early-phase scan

Correction to: A bis-boron boramino acid PET tracer for brain tumor diagnosis

A bis-boron boramino acid PET tracer for brain tumor diagnosis